1-20 of 211
Yi Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

Clinical Trials & Observations
Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick Stiff, Ian W. Flinn, Umar Farooq, Andre H. Goy, Peter A. McSweeney, Javier Munoz, Tanya Siddiqi, Julio C. Chavez, Alex F. Herrera, Nancy L. Bartlett, Adrian A. Bot, Rhine R. Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J. Kim, Yan Zheng, Frederick L. Locke
Journal: Blood
Blood (2023) 141 (19): 2307–2315.
DOI: https://doi.org/10.1182/blood.2022018893
Published: 2023
Includes: Supplemental data
Journal Articles

Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (axi-cel) in Patients with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Real-World Practice Patterns and Outcomes

Arushi Khurana, Megumi Bailey, Madiha Iqbal, Radhika Bansal, Catherine J. Lee, Bradley Hunter, Matthew A. Lunning, Samantha Jaglowski, Michael D. Jain, Saurabh Dahiya, Veronika Bachanova, Umar Farooq, Sairah Ahmed, Brian T. Hill, Javier L. Munoz, Krish Patel, Olalekan O. Oluwole, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 4657–4660.
DOI: https://doi.org/10.1182/blood-2022-170486
Published: 2022
Journal Articles

Efficacy Outcomes and Characteristics of Patients with Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity after Treatment with Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1

Nikhil C. Munshi, Bruno Paiva, Thomas Martin, Saad Usmani, Yi Lin, Jordan M. Schecter, Carolyn C. Jackson, Deepu Madduri, Enrique Zudaire, Tzu-min Yeh, J. Blake Bartlett, Lida Pacaud, Muhammad Akram, Dong Geng, Sundar Jagannath, Adam D. Cohen, Jesús San-Miguel
Journal: Blood
Blood (2022) 140 (Supplement 1): 4652–4654.
DOI: https://doi.org/10.1182/blood-2022-159141
Published: 2022
Journal Articles

Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O'Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 3158–3161.
DOI: https://doi.org/10.1182/blood-2022-158248
Published: 2022
Journal Articles

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma

Radhika Bansal, Sikander Ailawadhi, Jeremy T. Larsen, Morie A Gertz, Matthew A. Hathcock, David Dingli, Prashant Kapoor, Taxiarchis Kourelis, Suzanne R. Hayman, Rahma M Warsame, Moritz Binder, Ricardo D Parrondo, Rafael Fonseca, P. Leif Bergsagel, Shaji K Kumar, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 1862–1864.
DOI: https://doi.org/10.1182/blood-2022-166662
Published: 2022
Journal Articles

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy T. Larsen, P. Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Wilson I. Gonsalves, Ronald Go, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma M Warsame, Amie Fonder, Miriam A. Hobbs, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10017–10019.
DOI: https://doi.org/10.1182/blood-2022-167181
Published: 2022
Journal Articles

Real-World Impact of Time from Leukapheresis to Infusion (Vein-to-Vein Time) in Patients with Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel

Frederick L. Locke, Zhen-Huan Hu, Tanya Siddiqi, Caron A. Jacobson, Sarah Nikiforow, Sairah Ahmed, David B. Miklos, Yi Lin, Matthew A. Lunning, Brian T. Hill, Armin Ghobadi, Harry Miao, Shilpa Shahani, Clare Spooner, Christine Fu, Anik R. Patel, Hairong Xu, Marcelo C Pasquini
Journal: Blood
Blood (2022) 140 (Supplement 1): 7512–7515.
DOI: https://doi.org/10.1182/blood-2022-155603
Published: 2022
Journal Articles

The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M. Logue, Ciara L. Freeman, Melissa Alsina, Sebastian Theurich, Frederick L. Locke, Emmanuel Bachy, Michael D. Jain, Yi Lin, Marion Subklewe
Journal: Blood
Blood (2022) 140 (Supplement 1): 7506–7508.
DOI: https://doi.org/10.1182/blood-2022-165266
Published: 2022
Journal Articles

HZ-a-018 Is a Highly Selective and Potent BTK Inhibitor with CNS-Penetrating Profile for Central Nervous System Lymphoma

Zhuang Kang, Feng Chen, Yi Lin, Xianggui Yuan, Xi Chen, Wenbin Qian, Haiyan Yang, Miao Hu, Xingguo Liu, Xinglu Zhou, Wenbin Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12064.
DOI: https://doi.org/10.1182/blood-2022-166776
Published: 2022
Journal Articles

Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6

Olalekan O. Oluwole, Edouard Forcade, Javier Muñoz, Sophie de Guibert, Julie M. Vose, Nancy L. Bartlett, Yi Lin, Abhinav Deol, Peter A. McSweeney, Andre H. Goy, Marie José Kersten, Caron A. Jacobson, Umar Farooq, Monique C. Minnema, Catherine Thieblemont, John Timmerman, Patrick Stiff, Irit Avivi, Dimitrios Tzachanis, Yan Zheng, Saran Vardhanabhuti, Jenny Nater, Rhine R. Shen, Harry Miao, Jenny Kim, Tom van Meerten
Journal: Blood
Blood (2022) 140 (Supplement 1): 10399–10401.
DOI: https://doi.org/10.1182/blood-2022-156117
Published: 2022
Journal Articles

Efficacy of CD19 Directed Therapies in Large B-Cell Lymphoma (LBCL) Relapsing after Chimeric Antigen Receptor (CAR) T-Cell Therapy

Madiha Iqbal, Arushi Khurana, Julio Chavez, Allison C. Rosenthal, Zhuo Li, Emily Craver, Saha Aditi, Narendranath Epperla, Kaitlin Annunzio, Farrukh T. Awan, Iris Isufi, Bhagirathbhai Dholaria, Shakthi Bhaskar, Joseph Maakaron, Nuttavut Sumransub, Andrew Fijalka, Jose Sandoval-Sus, Stanislav Ivanov, Yi Lin, Mohamed A. Kharfan-Dabaja
Journal: Blood
Blood (2022) 140 (Supplement 1): 10396–10398.
DOI: https://doi.org/10.1182/blood-2022-169689
Published: 2022
Journal Articles

Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort

Sanjal H Desai, Marcus P. Watkins, Reem Karmali, Gaurav Goyal, Mitchell Hughes, Arushi Khurana, Francisco Hernandez-Ilizaliturri, Nuttavut Sumransub, Joanna Zurko, Imran A. Nizamuddin, Haris Hatic, Daniel A Landsburg, Andrea Anampa-Guzman, Mehdi Hamadani, Yi Lin, Iris Isufi, Aung M Tun, Brian T. Hill, Deborah M. Stephens, Paolo F Caimi, Daniel A. Ermann, Brad S. Kahl, Grzegorz S. Nowakowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 10391–10393.
DOI: https://doi.org/10.1182/blood-2022-159725
Published: 2022
Journal Articles

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Jason N Barreto, Erin F Barreto, Kristin C. Mara, Andrew D. Rule, Marissa Z. Powell, Radhika Bansal, Matthew A. Hathcock, Sandra M. Herrmann, Adrienne N. Nedved, Stephen M. Ansell, N. Nora Bennani, Jonas Paludo, Patrick B. Johnston, Urshila Durani, Tyler B. Sandahl, Yucai Wang, Arushi Khurana, Hassan B. Alkhateeb, Mithun V. Shah, Prashant Kapoor, Morie A Gertz, Shaji K Kumar, David Dingli, Taxiarchis Kourelis, Rahma M Warsame, Suzanne R. Hayman, Nelson Leung, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 10942–10944.
DOI: https://doi.org/10.1182/blood-2022-164785
Published: 2022
Journal Articles

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Andrea Angioi, Moritz Binder, Nelson Leung, Frank Bridoux, Camille Cohen, David Dingli, Angela Dispenzieri, Parikshit Duriseti, Roberta Fenoglio, Amie Fonder, Morie A. Gertz, Ronald Go, Wilson I. Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Prashant Kapoor, Bertrand Knebelmann, Taxiarchis Kourelis, Shaji K Kumar, Robert A. Kyle, Martha Q. Lacy, Nicola Lepori, Yi Lin, Shveta Motwani, Eli Muchtar, Samih Nasr, Antonello Pani, Dario Roccatello, Virginie Royal, Paul Sanders, Stephan Troyanov, Christopher P. Venner, Rahma M Warsame, Niloufarsadat Yarandi, S. Vincent Rajkumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10068–10070.
DOI: https://doi.org/10.1182/blood-2022-162754
Published: 2022
Journal Articles

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Radhika Bansal, Jonas Paludo, Matthew A. Hathcock, Megan T Spychalla, Arushi Khurana, Paul J. Hampel, Urshila Durani, Hassan B. Alkhateeb, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Yucai Wang, Saad S. Kenderian, Moritz Binder, Taxiarchis Kourelis, Shaji K Kumar, Mithun V. Shah, Rahma M Warsame, N. Nora Bennani, Morie A Gertz, Patrick B. Johnston, Stephen M. Ansell, Mustaqeem A. Siddiqui, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 2399–2401.
DOI: https://doi.org/10.1182/blood-2022-167187
Published: 2022
Journal Articles

Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

Charles Gaulin, Matthew Ulrickson, Muhammad Husnain, Madiha Iqbal, Paschalis Vergidis, Allison C. Rosenthal, Hemant S. Murthy, Carolyn Mead-Harvey, Yucai Wang, Januario E. Castro, Jeanne M. Palmer, Jose F. Leis, Patrick B. Johnston, Janis E. Blair, Mohamed A. Kharfan-Dabaja, Yi Lin, Javier Munoz
Journal: Blood
Blood (2022) 140 (Supplement 1): 12111–12113.
DOI: https://doi.org/10.1182/blood-2022-159744
Published: 2022
Journal Articles

CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL

Richard Curtis Godby, Asmaa Ferdjallah, Hassan B. Alkhateeb, Victor Aquino, Michelle P. Hudspeth, Hemalatha G. Rangarajan, Carrie Lynn Kitko, Eric Jon Anderson, Susan Kelly, Arunkumar J. Modi, Emmanuel Katsanis, Shanti Ramachandran, Yi Lin, Mira A Kohorst
Journal: Blood
Blood (2022) 140 (Supplement 1): 12762–12763.
DOI: https://doi.org/10.1182/blood-2022-163390
Published: 2022
Journal Articles

Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide

Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K. Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A. Gertz, Wilson I. Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma M Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 9998–9999.
DOI: https://doi.org/10.1182/blood-2022-160368
Published: 2022
Journal Articles

Muscle and Fat Composition in Patients with Newly Diagnosed Multiple Myeloma

Nadine Abdallah, Hiroki Nagayama, Naoki Takahashi, Wilson I. Gonsalves, Amie Fonder, Angela Dispenzieri, David Dingli, Francis K. Buadi, Martha Q. Lacy, Miriam A. Hobbs, Morie A. Gertz, Moritz Binder, Prashant Kapoor, Rahma M Warsame, Suzanne R. Hayman, Taxiarchis Kourelis, Yi L. Hwa, Yi Lin, Robert A. Kyle, S. Vincent Rajkumar, Stephen Broski, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 7141–7143.
DOI: https://doi.org/10.1182/blood-2022-163746
Published: 2022
Journal Articles

Outcomes of Axicabtagene Ciloleucel in Comparison with Chemoimmunotherapy (CIT) in an Elderly Population for Treatment of Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) after Two or More Lines of Prior Therapy

Matthew A. Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Sairah Ahmed, David B. Miklos, Yi Lin, Brian T. Hill, Armin Ghobadi, Sattva S. Neelapu, Jason Westin, Harry Miao, Shilpa Shahani, Anik R. Patel, Clare Spooner, Christine Fu, Hairong Xu, Marcelo C Pasquini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1852–1855.
DOI: https://doi.org/10.1182/blood-2022-162421
Published: 2022